
-
UK lawmakers begin emergency debate to save British Steel
-
Accord reached 'in principle' over tackling future pandemics: negotiating body
-
Hamas expects 'real progress' in Cairo talks to end Gaza war
-
Lady Gaga brings mayhem to the desert on Coachella day one
-
UN warns US aid cuts threaten millions of Afghans with famine
-
Japan PM warns of divided world at futuristic World Expo opening ceremony
-
Junta chief frontrunner as Gabon holds first election since 2023 coup
-
Iran delegation in Oman for high-stakes nuclear talks with US
-
Australia beat Colombia to end BJK Cup bid on winning note
-
German refinery's plight prompts calls for return of Russian oil
-
Trump carves up world and international order with it
-
Paris theatre soul-searching after allegations of sexual abuse
-
US, Iran to hold high-stakes nuclear talks
-
Frustrated families await news days after 222 killed in Dominican club disaster
-
Jokic triple double as Denver fight back for big win
-
Trump envoy suggests allied zones of control in Ukraine
-
Iraqi markets a haven for pedlars escaping Iran's economic woes
-
Chinese manufacturers in fighting spirits despite scrapped US orders
-
Argentina receives $42 bn from international financial institutions
-
Menendez brothers' resentencing can go ahead: LA judge rules
-
'Hard on the body': Canadian troops train for Arctic defense
-
Trump, 78, says feels in 'very good shape' after annual checkup
-
McKellar 'very, very proud' after 'Tahs tame rampant Chiefs
-
Man executed by firing squad in South Carolina
-
Defending champ Scheffler three back after tough day at Augusta
-
Ballester apologizes to Augusta National for relief in Rae's Creek
-
Scorching Coachella kicks off as Lady Gaga set to helm main stage
-
McIlroy, DeChambeau charge but Rose clings to Masters lead
-
Langer misses cut to bring 41st and final Masters appearance to a close
-
Ecuador presidential hopefuls make last pitch to voters
-
Rose knocking on the door of a major again at the Masters
-
DeChambeau finding right balance at Augusta National
-
Spurs leaker not a player says Postecoglou
-
All Black Barrett helps Leinster into Champions Cup semis
-
Round-two rebound: Resilient McIlroy right back in the Masters hunt
-
Asset flight challenges US safe haven status
-
Menendez brothers appear in LA court for resentencing hearing
-
McIlroy, DeChambeau charge as Rose clings to Masters lead
-
UN seeks $275 million in aid for Myanmar quake survivors
-
Frustrated families await news days after 221 killed in Dominican club disaster
-
Trump wants to halt climate research by key agency: reports
-
Fed official says 'absolutely' ready to intervene in financial markets
-
Slumping Homa happy to be headed into weekend at the Masters
-
Morbidelli fastest ahead of cagey MotoGP title rivals in Qatar practise
-
Musetti stuns Monte Carlo Masters champion Tsitsipas to reach semis
-
Abuse scandal returns to haunt the flying 'butterflies' of Italian gymnastics
-
Trump defends policy after China hits US with 125% tariffs
-
Frustrated families await news days after Dominican club disaster
-
McLarens dominate Bahrain practice, Verstappen rues 'too slow' Red Bull
-
Eight birdies rescue Masters rookie McCarty after horror start

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11
NEW YORK, NY / ACCESS Newswire / March 6, 2025 / Bill Enright, CEO and Gemma Brown, CFO of Barinthus Biotherapeutics plc, will be presenting at this year's Investor Summit Virtual on March 11th.
About Barinthus Biotherapeutics plc
Barinthus Biotherapeutics (NASDAQ:BRNS) is a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates designed to guide the immune system to overcome autoimmunity and chronic infectious diseases. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Bio. With a focused pipeline built around its proprietary platform technologies, Barinthus Bio is advancing immunotherapeutic product candidates in autoimmunity and infectious diseases, including: VTP-1000, utilizing the SNAP-Tolerance Immunotherapy (SNAP-TI) platform designed to treat people with celiac disease and VTP-300, that is utilizing the ChAdOx/MVA platform designed as a potential component of a functional cure for chronic HBV infection Further, it has license, research and development, and collaboration agreements with OUI, NIH, CanSino, CRUK; and Arbutus.
Event: Q1 Investor Summit
Presentation Time: 11:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52091
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are significantly undervalued and have a near-term catalyst.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
Access Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information
Please visit: https://investorsummitgroup.com/
Or, contact [email protected]
SOURCE: Barinthus Biotherapeutics plc
View the original press release on ACCESS Newswire
L.Miller--AMWN